Upload

Loading icon Loading...

This video is unavailable.

Melanotan (one) "afamelanotide" NBC News report, November 1991

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to like melanotan1's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to dislike melanotan1's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to add melanotan1's video to your playlist.

Uploaded on Jan 9, 2009

Melanotan (one) "afamelanotide" discovery by researchers at the University of Arizona in Tucson as explained by NBC News' Robert Bazell (with Tom Brokaw introduction) in a November 1991 News report. Melanotan (one) is now being developed in Australia as a photoprotective medicine to treat people who's skin is negatively affected (more than normal) by exposure to UV light. Clinuvel (originally named "Epitan") is the company that has been working to develop it since 1999. They are currently conducting clinical trials (under the drug name "afamelanotide"). The expected release of Melanotan one on the market as a treatment option for Erythropoietic Protoporphyria (EPP) sufferers is likely to be either 2009 or 2010.

Journal of the American Medical Association article that this report was based upon:
http://jama.ama-assn.org/cgi/content/...

http://www.clinuvel.com/
http://en.wikipedia.org/wiki/Melanotan
http://melanotan.org/
afamelanotide

Loading icon Loading...

Loading icon Loading...

Loading icon Loading...

The interactive transcript could not be loaded.

Loading icon Loading...

Loading icon Loading...

Ratings have been disabled for this video.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.

Loading icon Loading...

Loading...
Working...
Sign in to add this to Watch Later

Add to